| Hans-Günter Meyer-Thompson | Hepatitiden
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals.
Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals.
Finkelmeier F, Dultz G, Peiffer KH, Kronenberger B, Krauss F, Zeuzem S, Sarrazin C, Vermehren J, Waidmann O.
Liver Cancer. 2018 May;7(2):190-204. doi: 10.1159/000486812.